Skip to main content
PAVmed Inc. logo

PAVmed Inc. — Investor Relations & Filings

Ticker · PAVM ISIN · US70387R1068 LEI · 549300V1JXXVXU7P8007 US Professional, scientific and technical activities
Open in API
Filings indexed 648 across all filing types
Latest filing 2026-05-15 Earnings Release
Country US United States of America
Listing US PAVM

About PAVmed Inc.

https://pavmed.com/

PAVmed Inc. is a commercial-stage, diversified medical technology company that develops and commercializes products across the medical device, diagnostics, and digital health sectors. The company operates through a shared-services business model to support its majority-owned subsidiaries. Its key subsidiary, Lucid Diagnostics, offers the EsoGuard® Esophageal DNA Test, a diagnostic tool for the early detection of esophageal precancer. Another subsidiary, Veris Health, provides a digital health platform for remote patient monitoring to enhance personalized cancer care. PAVmed's strategy focuses on acquiring and developing early-stage medical technologies to address unmet clinical needs for patients and healthcare systems.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 87% confidence The document is a Form 8-K current report filed under Sections 2.02 and 7.01, with Item 2.02 specifically stating that a press release was issued announcing financial results for the fiscal quarter ended March 31, 2026. This is the typical format for a quarterly earnings release filed via Form 8-K. Therefore, it should be classified as an Earnings Release. Q1 2026
2026-05-15 English
FORM 10-Q
Interim / Quarterly Report
2026-05-14 English
DEF 14A - PAVmed Inc. (0001624326) (Filer)
Proxy Solicitation & Information Statement
2026-05-01 English
ARS - PAVmed Inc. (0001624326) (Filer)
Annual Report
2026-04-30 English
8-K - PAVmed Inc. (0001624326) (Filer)
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text specifically mentions "Item 2.02. Results of Operations and Financial Condition" and states that a press release announcing financial results for the fiscal year ended December 31, 2025, is attached as an exhibit. The document itself does not contain detailed financial statements or comprehensive analysis but rather references a press release with financial results. The length of the document is 4151 characters, which is relatively short and consistent with a current report rather than a full annual report or detailed earnings release. The Form 8-K is primarily an announcement of financial results and business updates, not the full report itself. Therefore, the best classification is Earnings Release (ER), as it corresponds to the initial announcement of quarterly or annual financial results with key highlights only, typically disseminated via press release and Form 8-K filing.
2026-03-30 English
10-K - PAVmed Inc. (0001624326) (Filer)
Annual Report FY 2025
2026-03-27 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.